Ganglioside metabolism in a transgenic mouse model of alzheimer's disease: Expression of chol-1α antigens in the brain

Toshio Ariga, Makoto Yanagisawa, Chandramohan Wakade, Susumu Ando, Jerry J. Buccafusco, Michael P. McDonald, Robert K. Yu

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The accumulation of Aβ (amyloid β-protein) is one of the major pathological hallmarks in AD (Alzheimer's disease). Gangliosides, sialic acid-containing glycosphingolipids enriched in the nervous system and frequently used as biomarkers associated with the biochemical pathology of neurological disorders, have been suggested to be involved in the initial aggregation of Aβ. In the present study, we have examined ganglioside metabolism in the brain of a double-Tg (transgenic) mouse model of AD that co-expresses mouse/human chimaeric APP (amyloid precursor protein) with the Swedish mutation and human presenilin-1 with a deletion of exon 9. Although accumulation of Aβ was confirmed in the double-Tg mouse brains and sera, no statistically significant change was detected in the concentration and composition of major ganglio-N-tetraosyl-series gangliosides in the double-Tg brain. Most interestingly, Chol-1α antigens (cholinergic neuron-specific gangliosides), such as GT1aα and GQ1bα, which are minor species in the brain, were found to be increased in the double-Tg mouse brain. We interpret that the occurrence of these gangliosides may represent evidence for generation of cholinergic neurons in the AD brain, as a result of compensatory neurogenesis activated by the presence of Aβ.

Original languageEnglish (US)
Pages (from-to)233-241
Number of pages9
JournalASN Neuro
Volume2
Issue number4
DOIs
StatePublished - Oct 29 2010

Fingerprint

Gangliosides
Transgenic Mice
Alzheimer Disease
Brain
Cholinergic Neurons
Serum Amyloid A Protein
Glycosphingolipids
Amyloid beta-Protein Precursor
Neurogenesis
N-Acetylneuraminic Acid
Nervous System Diseases
Nervous System
chol-1 antigen
Exons
Biomarkers
Pathology
Mutation
Serum

Keywords

  • Alzheimer's disease
  • Amyloid β-peptide
  • Antigen
  • Chol-1α
  • Cholinergic neuron
  • Ganglioside
  • Transgenic mouse

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Ganglioside metabolism in a transgenic mouse model of alzheimer's disease : Expression of chol-1α antigens in the brain. / Ariga, Toshio; Yanagisawa, Makoto; Wakade, Chandramohan; Ando, Susumu; Buccafusco, Jerry J.; McDonald, Michael P.; Yu, Robert K.

In: ASN Neuro, Vol. 2, No. 4, 29.10.2010, p. 233-241.

Research output: Contribution to journalArticle

Ariga, Toshio ; Yanagisawa, Makoto ; Wakade, Chandramohan ; Ando, Susumu ; Buccafusco, Jerry J. ; McDonald, Michael P. ; Yu, Robert K. / Ganglioside metabolism in a transgenic mouse model of alzheimer's disease : Expression of chol-1α antigens in the brain. In: ASN Neuro. 2010 ; Vol. 2, No. 4. pp. 233-241.
@article{f2a390a490734fe592efb24512c03b74,
title = "Ganglioside metabolism in a transgenic mouse model of alzheimer's disease: Expression of chol-1α antigens in the brain",
abstract = "The accumulation of Aβ (amyloid β-protein) is one of the major pathological hallmarks in AD (Alzheimer's disease). Gangliosides, sialic acid-containing glycosphingolipids enriched in the nervous system and frequently used as biomarkers associated with the biochemical pathology of neurological disorders, have been suggested to be involved in the initial aggregation of Aβ. In the present study, we have examined ganglioside metabolism in the brain of a double-Tg (transgenic) mouse model of AD that co-expresses mouse/human chimaeric APP (amyloid precursor protein) with the Swedish mutation and human presenilin-1 with a deletion of exon 9. Although accumulation of Aβ was confirmed in the double-Tg mouse brains and sera, no statistically significant change was detected in the concentration and composition of major ganglio-N-tetraosyl-series gangliosides in the double-Tg brain. Most interestingly, Chol-1α antigens (cholinergic neuron-specific gangliosides), such as GT1aα and GQ1bα, which are minor species in the brain, were found to be increased in the double-Tg mouse brain. We interpret that the occurrence of these gangliosides may represent evidence for generation of cholinergic neurons in the AD brain, as a result of compensatory neurogenesis activated by the presence of Aβ.",
keywords = "Alzheimer's disease, Amyloid β-peptide, Antigen, Chol-1α, Cholinergic neuron, Ganglioside, Transgenic mouse",
author = "Toshio Ariga and Makoto Yanagisawa and Chandramohan Wakade and Susumu Ando and Buccafusco, {Jerry J.} and McDonald, {Michael P.} and Yu, {Robert K.}",
year = "2010",
month = "10",
day = "29",
doi = "10.1042/AN20100021",
language = "English (US)",
volume = "2",
pages = "233--241",
journal = "ASN Neuro",
issn = "1759-0914",
publisher = "Portland Press Ltd.",
number = "4",

}

TY - JOUR

T1 - Ganglioside metabolism in a transgenic mouse model of alzheimer's disease

T2 - Expression of chol-1α antigens in the brain

AU - Ariga, Toshio

AU - Yanagisawa, Makoto

AU - Wakade, Chandramohan

AU - Ando, Susumu

AU - Buccafusco, Jerry J.

AU - McDonald, Michael P.

AU - Yu, Robert K.

PY - 2010/10/29

Y1 - 2010/10/29

N2 - The accumulation of Aβ (amyloid β-protein) is one of the major pathological hallmarks in AD (Alzheimer's disease). Gangliosides, sialic acid-containing glycosphingolipids enriched in the nervous system and frequently used as biomarkers associated with the biochemical pathology of neurological disorders, have been suggested to be involved in the initial aggregation of Aβ. In the present study, we have examined ganglioside metabolism in the brain of a double-Tg (transgenic) mouse model of AD that co-expresses mouse/human chimaeric APP (amyloid precursor protein) with the Swedish mutation and human presenilin-1 with a deletion of exon 9. Although accumulation of Aβ was confirmed in the double-Tg mouse brains and sera, no statistically significant change was detected in the concentration and composition of major ganglio-N-tetraosyl-series gangliosides in the double-Tg brain. Most interestingly, Chol-1α antigens (cholinergic neuron-specific gangliosides), such as GT1aα and GQ1bα, which are minor species in the brain, were found to be increased in the double-Tg mouse brain. We interpret that the occurrence of these gangliosides may represent evidence for generation of cholinergic neurons in the AD brain, as a result of compensatory neurogenesis activated by the presence of Aβ.

AB - The accumulation of Aβ (amyloid β-protein) is one of the major pathological hallmarks in AD (Alzheimer's disease). Gangliosides, sialic acid-containing glycosphingolipids enriched in the nervous system and frequently used as biomarkers associated with the biochemical pathology of neurological disorders, have been suggested to be involved in the initial aggregation of Aβ. In the present study, we have examined ganglioside metabolism in the brain of a double-Tg (transgenic) mouse model of AD that co-expresses mouse/human chimaeric APP (amyloid precursor protein) with the Swedish mutation and human presenilin-1 with a deletion of exon 9. Although accumulation of Aβ was confirmed in the double-Tg mouse brains and sera, no statistically significant change was detected in the concentration and composition of major ganglio-N-tetraosyl-series gangliosides in the double-Tg brain. Most interestingly, Chol-1α antigens (cholinergic neuron-specific gangliosides), such as GT1aα and GQ1bα, which are minor species in the brain, were found to be increased in the double-Tg mouse brain. We interpret that the occurrence of these gangliosides may represent evidence for generation of cholinergic neurons in the AD brain, as a result of compensatory neurogenesis activated by the presence of Aβ.

KW - Alzheimer's disease

KW - Amyloid β-peptide

KW - Antigen

KW - Chol-1α

KW - Cholinergic neuron

KW - Ganglioside

KW - Transgenic mouse

UR - http://www.scopus.com/inward/record.url?scp=77958476883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958476883&partnerID=8YFLogxK

U2 - 10.1042/AN20100021

DO - 10.1042/AN20100021

M3 - Article

C2 - 20930939

AN - SCOPUS:77958476883

VL - 2

SP - 233

EP - 241

JO - ASN Neuro

JF - ASN Neuro

SN - 1759-0914

IS - 4

ER -